Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The company will also soon release the results of its STEP UP T2D trial, which tested a 7.2 milligram dose for people with obesity and type 2 diabetes
[1] This gradual accumulation helps explain why some patients notice digestive effects developing over the first month of treatment
It comes in pre-filled pens at standardized doses
Your review * Your review * Great service
Pharmaceutical manufacturers must reevaluate the list price and implement more affordability programs to help consumers prescribed GIP and GLP-1 medications for obesity
US$ 21.79
US$ 25.00
US$ 25.39
US$ 29.51
US$ 28.53
